Clinical trials
Lung Diseases, Interstitial trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 7 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 10 |
| 2024 | 6 |
| 2025 | 10 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
| Unknown status | 18 |
| Completed | 16 |
| Not yet recruiting | 6 |
| Active, not recruiting | 5 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 7 |
| Guangzhou Institute of Respiratory Disease | 4 |
| Peking Union Medical College Hospital | 4 |
| China-Japan Friendship Hospital | 3 |
| GlaxoSmithKline | 3 |
| The First Affiliated Hospital of Guangzhou Medical University | 3 |
| Bristol-Myers Squibb | 2 |
| Children's Hospital of Fudan University | 2 |
| Kyntra Bio | 2 |
| Qilu Hospital of Shandong University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 66 |
| Pulmonary Fibrosis | 7 |
| Connective Tissue Diseases | 6 |
| Idiopathic Pulmonary Fibrosis | 6 |
| Arthritis, Rheumatoid | 5 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Scleroderma, Diffuse | 4 |
| Scleroderma, Systemic | 4 |
| Idiopathic Interstitial Pneumonias | 3 |
| Lung Diseases | 3 |
Trials
Showing 51 to 66 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.